the eastern cooperative oncology group evaluated cyclophosphamide 600 mg/m2 intravenously daily x 4 ( total dose each cycle 2400 mg/m2 ) as an aggressive approach to the treatment of patients with advanced multiple myeloma .
C0010583
cyclophosphamide
C0026764
multiple myeloma